NovaBone launches bioactive bone graft substitutes

NovaBone Products added NovaBone IRM and IRM MacroPOR to its portfolio of biologically active bone graft substitutes today.

The Jacksonville, Fla.-based company touted its devices as the industry’s most advanced bioactive synthetic bone graft substitutes available for orthopedic applications. The 2 new formulations are highly irrigation resistant and promote osteogenesis and osteoblastic activity, according to NovaBone.

“NovaBone Ppoducts’ base bioactive glass technology has proven to out-perform traditional calcium sulfate based synthetic products and demineralized bone matrix products,” Dennis McBride, VP of sales & marketing, said in prepared remarks. “We are now advancing our science further by providing formulations with carriers that have a synergistic effect in bone formation and retain molded shapes following implantation and irrigation.”

NovaBone offers minimally invasive delivery devices, strip formulations, putty materials that are hydrated using bone marrow aspirate and ready-to-use putty formulations.

“We are proud to offer products that allow a surgeon to look to 1 company when addressing bone grafting needs,” McBride added.